Table 3.
Treatment | IgG-7doa1 | IgG-14doa2 | IgM-14doa3 | AGP-40doa4 |
---|---|---|---|---|
μM | ||||
In ovo injection | ||||
Diluent5 | 2.39 | 6.52bc | 2.37c | 2.92 |
D36 | 2.26 | 6.43c | 2.42bc | 2.93 |
25OHD37 | 2.34 | 6.63a | 2.48ab | 2.72 |
D3+25OHD38 | 2.34 | 6.58ab | 2.57a | 2.86 |
Diet9 | ||||
Commercial | 2.32 | 6.58 | 2.42 | 2.86 |
ReCaP | 2.35 | 6.50 | 2.50 | 2.82 |
Pooled SEM | 0.049 | 0.053 | 0.045 | 0.009 |
P value | ||||
In ovo | 0.302 | 0.013 | 0.005 | 0.079 |
Diet | 0.570 | 0.090 | 0.080 | 0.580 |
In ovo x Diet | 0.302 | 0.984 | 0.974 | 0.129 |
a,bTreatment means within the same variable column within type of treatment with no common superscript differ significantly (P < 0.05).
Plasma IgG concentrations at 7 doa.
Plasma IgG concentrations at 14 doa.
Plasma IgM concentrations at 14 doa.
Plasma AGP concentrations at 40 doa.
Eggs injected with 50 μL commercial diluent at d 18 of incubation.
Eggs injected with 50 μL commercial diluent containing vitamin D3 at 2.4 μg at d 18 of incubation.
Eggs injected with 50 μL commercial diluent containing 25OHD3 at 2.4 μg/ at d 18 of incubation.
Eggs injected with 50 μL commercial diluent containing D3 at 2.4 and 25OHD3 at 2.4 μg at d 18 of incubation.
A diet restricted Ca and available P by 20% through the rearing period.